Lifestyle app for mpn patients
Part of Blood & lymphatic, Cancer clinical trials.
This trial is testing a digital lifestyle app designed to help people with myeloproliferative neoplasms (MPNs) manage their health and wellness. By using the app, you may get support in tracking symptoms, lifestyle habits, and connecting with resources that could improve your quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a myeloproliferative neoplasm (MPN), such as polycythemia vera, essential thrombocythemia, or myelofibrosis.
- You are 18 years old or older.
- You can read, speak, and understand English.
- You are able to give your informed consent to be part of the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This observational registry tracks symptoms, treatments, and disease changes over time in people diagnosed with myeloproliferative neoplasms (MPNs). By joining, you help doctors learn more about the condition and possibly contribute to better future care.
This pilot study tests a lifestyle and movement program for adults with certain myeloproliferative neoplasms (MPNs), aiming to improve well-being through safe exercise habits. You may be considered if you have an MPN and at least one heart-related risk factor.
This study tests a digital application to help patients with acute myeloid leukemia (AML) during their hospital stay. It may assist with tracking symptoms, education, or communication with care teams.
This study uses a smartphone app and a wearable watch to track your symptoms and daily activity. The information may help doctors better understand and manage MPN, and could lead to improved care.
This trial tests a digital app designed to help people with multiple myeloma (a blood cancer) manage their quality of life and symptoms. The study wants to see if using this app on a phone or computer can help patients feel better and stay connected to their care.
This study tests a digital health app to help you manage symptoms and stay connected with your care team while receiving CAR-T therapy as an outpatient. It's designed for people with blood cancers who have a caregiver living with them.
Hear when a new Myeloproliferative Neoplasms (MPNs) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.